Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 301–400 of 1,001
Bourassa, M. W., Brown, H. H., Borchelt, D., Vogt, S., & Miller, L. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00110 · Cited by 78
Cyclic Amplification of Protein Misfolding and Aggregation
Saá, P., Castilla, J., & Soto, C. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-874-9:053 · Cited by 71
Self-citationIn the Footsteps of Alchemists
Dobson, C. M. (2004) · Science · doi:10.1126/science.1093078 · Cited by 71
Agrin binds α-synuclein and modulates α-synuclein fibrillation
Liu, I., Uversky, V. N., Munishkina, L. A., Fink, A. L., Halfter, W. M., & Cole, G. J. (2005) · Glycobiology · doi:10.1093/glycob/cwj014 · Cited by 72
“…demonstrate that these, and many other human diseases, are protein conformational disorders characterized by the formation of unstable protein intermediates that lead to the formation of amyloid protein fibrils and neuronal degeneration (Carrell and Lomas, 1997; Soto, 2003; Uversky and Fink, 2004).”
BackgroundInfluentialPolyglutamine expansion diseases: failing to deliver
Morfini, G. A., Pigino, G. F., & Brady, S. T. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.002 · Cited by 80
α-Synuclein oligomers form by secondary nucleation
Xu, C. K., Meisl, G., Andrzejewska, E. A., Krainer, G., Dear, A. J., Castellana-Cruz, M., Turi, S., Edu, I. A., Vivacqua, G., Jacquat, R. P. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50692-4 · Cited by 87
“In PD, aggregates of the 14 kDa protein α-synuclein are the major component of Lewy bodies and neurites, which emerge as the pathological hallmarks of the disease [2].”
The Prion Hypothesis of Parkinson’s Disease
Chu, Y., & Kordower, J. H. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0549-x · Cited by 88
The Unfolded Protein Response Regulates Glutamate Receptor Export from the Endoplasmic Reticulum
Shim, J., Umemura, T., Nothstein, E., & Rongo, C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0108 · Cited by 69
“One common link in many neuropathologies is the production of misfolded and/or aggregated proteins, which accumulate and eventually cause neuronal loss (Paschen and Frandsen, 2001; Kudo et al., 2002; Soto, 2003).”
BackgroundCandelise, N., Scaricamazza, S., Salvatori, I., Ferri, A., Valle, C., Manganelli, V., Garofalo, T., Sorice, M., & Misasi, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116016 · Cited by 78
Vijayalakshmi, K., Alladi, P. A., Ghosh, S., Prasanna, V., Sagar, B. C., Nalini, A., Sathyaprabha, T. N., & Raju, T. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.005 · Cited by 75
“Accumulation of misfolded/ unfolded proteins affects various cell signaling systems as well as neuronal connectivity (Bence et al., 2001; Lindholm et al., 2006; Soto, 2003).”
BackgroundChen, X., & Ren, C. L. (2017) · RSC Advances · doi:10.1039/c7ra02336g · Cited by 58
Katt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 71
Lipids in Amyloid-β Processing, Aggregation, and Toxicity
Morgado, I., & Garvey, M. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 71
The Transmissible Spongiform Encephalopathies of Livestock
Greenlee, J. J., & Greenlee, M. H. W. (2015) · ILAR Journal · doi:10.1093/ilar/ilv008 · Cited by 71
“…sclerosis (ALS), and Huntington's disease, in which misfolded disease-associated proteins catalyze a refolding of normal cellular protein that accumulates and is associated with neural degeneration (Fernandez-Borges et al. 2013; Hetz et al. 2003; Prusiner 2013; Soto 2003; Soto and Satani 2011).”
BackgroundHuang, M., Liu, Y. U., Yao, X., Qin, D., & Su, H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00416-x · Cited by 64
“Protein aggregates in the neural system are pathological characteristics of neurodegenerative diseases, such as beta-amyloid in Alzheimer’s disease and alpha-synuclein in Parkinson’s disease, as well as SOD1 [147], TARDBP and FUS [148–150] in ALS.”
BackgroundPerni, M., Challa, P. K., Kirkegaard, J. B., Limbocker, R., Koopman, M., Hardenberg, M. C., Sormanni, P., Müller, T., Saar, K. L., Roode, L. W. Y., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.02.005 · Cited by 76
Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review
Essa, M. M., Moghadas, M., Ba-Omar, T., Qoronfleh, M. W., Guillemin, G. J., Manivasagam, T., Justin‐Thenmozhi, A., Ray, B., Bhat, A., Chidambaram, S. B., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9989-9 · Cited by 69
Chia, S., Flagmeier, P., Habchi, J., Lattanzi, V., Linse, S. S., Dobson, C. M., Knowles, T. P. J., & Vendruscolo, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700239114 · Cited by 68
Endoplasmic reticulum stress in diseases
Liu, Y., Xu, C., Gu, R., Han, R., Li, Z., & Xu, X. (2024) · MedComm · doi:10.1002/mco2.701 · Cited by 86
“108 Persistent activation of the UPR has emerged as a shared characteristic across diverse neurodegenerative diseases.”
BackgroundJin, Y., Sun, Y., Chen, Y., Lei, J., & Wei, G. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp01803d · Cited by 68
The Application of Functional Genomics to Alzheimer’s Disease
Cacabelos, R. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.5.597.23795 · Cited by 72
Erratum: De novo induction of amyloid-β deposition in vivo
Morales, R., Duran-Aniotz, C. A., Castilla, J., Estrada, L. D., & Soto, C. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.153 · Cited by 68
Self-citationCopper-Triggered Aggregation of Ubiquitin
Arnesano, F., Scintilla, S., Calò, V., Bonfrate, E., Ingrosso, C., Losacco, M., Pellegrino, T., Rizzarelli, E., & Natile, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007052 · Cited by 71
“common molecular mechanism involving protein misfolding and aggregation [4,5] and an increasing number of observations indicate that metal ions are capable of accelerating these processes”
BackgroundToxic effects of ethanol on bovine serum albumin
Liu, R., Qin, P., Wang, L., Zhao, X., Liu, Y., & Hao, X. (2010) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20314 · Cited by 66
“Many diseases such as cataract, mad cow disease, and diabetes are due to denaturation of proteins [3,4].”
BackgroundReview: Update on Classical and Atypical Scrapie in Sheep and Goats
Greenlee, J. J. (2018) · Veterinary Pathology · doi:10.1177/0300985818794247 · Cited by 65
Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases
Sin, O., Michels, H., & Nollen, E. A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.015 · Cited by 80
“To name a few, these can be the amyloid-beta in Alzheimer's disease (AD), mutant huntingtin in Huntington's disease (HD) and alpha-synuclein in Parkinson's disease (PD) [63].”
BackgroundInterruption of CryAB-Amyloid Oligomer Formation by HSP22
Sanbe, A., Yamauchi, J., Miyamoto, Y., Fujiwara, Y., Murabe, M., & Tanoue, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605481200 · Cited by 65
Prion-like features of misfolded Aβ and tau aggregates
Morales, R., Callegari, K., & Soto, C. A. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.031 · Cited by 70
Self-citationLi, C., Xiao, P., Gray, S. J., Weinberg, M. S., & Samulski, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109522108 · Cited by 66
“For example, superoxide dismutase 1 mutations result in protein aggregation that leads to amyotrophic lateral sclerosis, Alzheimer’s disease, and Huntington disease are related to mutant amyloid-β (Aβ) and huntingtin (Htt) protein accumulations, respectively (1).”
BackgroundNaeem, A., & Fazili, N. A. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9200-x · Cited by 79
“The passage of initially unfolded polypeptide chain through transition states can truly act as a ‘‘quality control’’ mechanism by which the problem of misfolding can be avoided [23].”
Liu, A. Y. C., Mathur, R., Mei, N., Langhammer, C. G., Babiarz, B., & Firestein, B. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158220 · Cited by 64
Van Dam, D., Vermeiren, Y., D. Dekker, A., J.W. Naudé, P., & P. De Deyn, P. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 65
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
Perez‐Lloret, S., Losada, M. E. O., Toblli, J. E., & Capani, F. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1371133 · Cited by 69
“neurons in the substantia nigra (SN) pars compacta, which leads the most typical motor symptoms [5].”
BackgroundCariulo, C., Azzollini, L., Verani, M., Martufi, P., Boggio, R., Chiki, A., DeGuire, S. M., Cherubini, M., Ginés, S., Marsh, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705372114 · Cited by 68
“Many neurodegenerative diseases are associated with accumulation and misfolding of specific proteins (3, 4), often associated with changes in PTM status.”
BackgroundStimulatory and Inhibitory Effects of Alkyl Bromide Surfactants on β-Amyloid Fibrillogenesis
Sabaté, R., & Estelrich, J. (2005) · Langmuir · doi:10.1021/la050472x · Cited by 65
Rowińska‐Żyrek, M., Salerno, M., & Kozłowski, H. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.03.026 · Cited by 73
Aggregation and Cellular Toxicity of Pathogenic or Non-pathogenic Proteins
Lee, S., Choi, M. C., Adem, K. A., Lukman, S., & Kim, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62062-3 · Cited by 68
Modelling neurodegenerative diseases with 3D brain organoids
Chang, Y., Kim, J., Park, H., Choi, H. G., & Kim, J. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12626 · Cited by 73
“The mechanisms underlying these NDDs are not fully understood, but ageing, genetics, protein misfolding, intracellular mechanisms, and programmed cell death have all been implicated (Meldrum & Garthwaite, 1990; Taylor, Hardy, & Fischbeck, 2002; Soto, 2003; Ross & Poirier, 2004).”
BackgroundHalloran, M., Parakh, S., & Atkin, J. D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/797914 · Cited by 64
“These diseases are also frequently classified as protein conformational disorders in which protein aggregation occurs due to the exposure of hydrophobic regions [2].”
BackgroundThe UPR and synaptic dysfunction in neurodegeneration
Freeman, O. J., & Mallucci, G. R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.029 · Cited by 73
“…the concept of disrupted protein homeostasis through endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) (Soto, 2003, Hetz and Mollereau, 2014, Halliday and Mallucci, 2015) and the closely related integrated stress response (ISR) (van 't Wout et al.,…”
BackgroundGiacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 79
Protein Aggregation in Retinal Cells and Approaches to Cell Protection
Surgucheva, I. G., Ninkina, N. N., Buchman, V. L., Grasing, K., & Surguchov, A. P. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-8474-1 · Cited by 65
“A recent discovery that most rhodopsin mutants are folding defective, places autosomal dominant RP within a family of conformational diseases that includes the majority of NDDs (Chapple et al., 2001; Soto, 2001, 2003; Illing et al., 2002; Lomas and Carell, 2002; Saliba et al., 2002; Chapple and Cheetham, 2003).”
BackgroundCACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics
Wan, J., Khanna, R., Sandusky, M., Papazian, D. M., Jen, J. C., & Baloh, R. W. (2005) · Neurology · doi:10.1212/01.wnl.0000167409.59089.c0 · Cited by 64
Assembly of natural and recombinant prion protein into fibrils
Leffers, K.-W., Wille, H., Stöhr, J., Junger, E., Prusiner, S. B., & Riesner, D. (2005) · Biological Chemistry · doi:10.1515/bc.2005.067 · Cited by 64
Potential for Stem Cells Therapy in Alzheimer’s Disease: Do Neurotrophic Factors Play Critical Role?
Bali, P., Lahiri, D., Banik, A., Nehru, B., & Anand, A. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160314145347 · Cited by 64
Abrams, J. L., Verghese, J., Gibney, P. A., & Morano, K. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530014 · Cited by 63
“In humans, protein misfolding and aggregation have been associated with the formation of amyloid deposits common to many neurodegenerative disorders including Alzheimer, Parkinson, and Huntington diseases (2).”
BackgroundNanoparticle‐Induced Folding and Fibril Formation of Coiled‐Coil‐Based Model Peptides
Wagner, S. C., Roskamp, M., Manjula, P., Araghi, R. R., Schlecht, S., & Koksch, B. (2010) · Small · doi:10.1002/smll.200902067 · Cited by 64
Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
Marsh, A. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0039-8 · Cited by 68
Limbocker, R., Mannini, B., Ruggeri, F. S., Cascella, R., Xu, C. K., Perni, M., Chia, S., Chen, S. W., Habchi, J., Bigi, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01140-8 · Cited by 65
Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases
Sousa, L., Guarda, M., Meneses, M. J., Macedo, M. P., & Miranda, H. V. (2021) · The Journal of Pathology · doi:10.1002/path.5777 · Cited by 77
“Upon cellular protein accumulation, misfolded proteins tend to self-associate and form larger, stable and non-functional protein aggregates [49].”
BackgroundTargeting the unfolded protein response for disease intervention.
Rivas, A., Vidal, R. L., & Hetz, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1053869 · Cited by 62
“Protein misfolding and abnormal aggregation is a common pathological feature observed in most neurodegenerative diseases including Huntington’s disease (HD), Parkinson’s disease (PD), Alzheimer ́s disease (AD), amyotrophic lateral sclerosis (ALS), a group of diseases that are classified as proteinmisfolding disorders…”
BackgroundTargeting Gpr52 lowers mutant HTT levels and rescues Huntington’s disease-associated phenotypes
Song, H., Li, H., Guo, S., Pan, Y., Fu, Y., Zhou, Z., Li, Z., Wen, X., Sun, X., He, B., et al. (2018) · Brain · doi:10.1093/brain/awy081 · Cited by 61
“A common hallmark for these diseases is the accumulation of misfolded and aggregationprone proteins, and lowering their levels is considered as an appealing therapeutic strategy (Soto, 2003).”
BackgroundSecond-Generation Pharmacological Chaperones: Beyond Inhibitors
Tran, M. L., Génisson, Y., Ballereau, S., & Dehoux, C. (2020) · Molecules · doi:10.3390/molecules25143145 · Cited by 63
Tak, Y. J., Park, J.-H., Rhim, H., & Kang, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207525 · Cited by 67
“Abnormal insoluble protein aggregation is a hallmark of several neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and ALS [20,21].”
BackgroundShining light on chiral inorganic nanomaterials for biological issues
Shao, Y., Yang, G., Lin, J.-Y., Fan, X., Guo, Y., Zhu, W., Cai, Y., Huang, H., Hu, D., Pang, W., et al. (2021) · Theranostics · doi:10.7150/thno.64511 · Cited by 62
“intra- or extracellular misfolded proteins/peptides [93], oxidative stress caused by ROS [94], and loss of functional neurons.”
BackgroundJanowska, M. K., Wu, K., & Baum, J. (2015) · Scientific Reports · doi:10.1038/srep15164 · Cited by 64
“Titration curves of 14N-MTSL labeled protein with 15N protein were fit using equation (1):”
MethodBulone, D., Masino, L., Thomas, D. J., Biagio, P. L. S., & Pastore, A. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000111 · Cited by 62
“has been described for several proteins that are known to form fibres and are associated with misfolding diseases [30].”
BackgroundXu, Y., Tian, C., Wang, S.-B., Xie, W.-L., Guo, Y., Zhang, J., Shi, Q., Chen, C., & Dong, X. (2012) · Autophagy · doi:10.4161/auto.21482 · Cited by 66
Talaei, F., van Praag, V. M., & Henning, R. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.011 · Cited by 65
Amyloid-Based Injectable Hydrogel Derived from Hydrolyzed Hen Egg White Lysozyme
Yang, L., Li, H., Yao, L., Yang, Y., & Ma, G. (2019) · ACS Omega · doi:10.1021/acsomega.8b03492 · Cited by 66
Wilkaniec, A., Gąssowska, M., Czapski, G. A., Cieślik, M., Sulkowski, G., & Adamczyk, A. (2017) · Purinergic Signalling · doi:10.1007/s11302-017-9567-2 · Cited by 61
Subcellular localization of the J-protein Sis1 regulates the heat shock response
Feder, Z. A., Ali, A., Singh, A., Krakowiak, J., Zheng, X., Bindokas, V. P., Wolfgeher, D. J., Kron, S. J., & Pincus, D. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202005165 · Cited by 59
“In addition to environmental sources, neurodegenerative disorders such as Parkinson ’ s disease and amyotrophic lateral sclerosis are characterized by protein aggregates and linked to deficits in PN components (Hipp et al., 2019; Labbadia and Morimoto, 2015; Soto, 2003).”
Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013011 · Cited by 77
“For example, prions autocatalytically self-assemble into amyloid structures, and numerous studies have revealed similarities in assembly pathways of both nonprion amyloidogenic proteins and prions (Soto, 2003).”
BackgroundChattopadhyay, M., Nwadibia, E. C., Strong, C. D., Gralla, E. B., Valentine, J. S., & Whitelegge, J. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666503 · Cited by 62
Kim, T., & Vemuganti, R. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17694186 · Cited by 63
“Furthermore, several proteins were shown to be associated with the progression of these disorders, particularly those that form aggregates in the CNS over time.(6,7) For instance, one of the pathological hallmarks of PD is the presence of Lewy Bodies, proteinaceous cytoplasmic inclusions mainly composed of aggregated…”
BackgroundGp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis
Joshi, V., Upadhyay, A., Kumar, A., & Mishra, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00259 · Cited by 70
“Proteins, which perform most of the cellular tasks, remain prone to misfold and aggregate inside the cytoplasm to form large inclusion bodies, as have been reported to cause a number of neurodegenerative diseases (Soto, 2003; Soto and Estrada, 2008; Chhangani and Mishra, 2013).”
BackgroundGiamblanco, N., Coglitore, D., Gubbiotti, A., Ma, T., Balanzat, E., Janot, J., Chinappi, M., & Balme, S. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03523 · Cited by 63
Jung, K. H., Kim, S. F., Liu, Y., & Zhang, X. (2019) · ChemBioChem · doi:10.1002/cbic.201800782 · Cited by 65
Unfolded Protein Response after Neurotrauma
Larner, S. F., Hayes, R. L., & Wang, K. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.807 · Cited by 64
“…of misfolded proteins that lead to cellular stress may be the pathological mechanism behind a diverse number of neurodegenerative diseases (Soto, 2003; Yuan and Yankner, 2000), often termed ER storage or conformational diseases, such as Alzheimer’s (Imaizumi et al., 2001; Kudo et al.,…”
How the Nucleus Copes with Proteotoxic Stress
Shibata, Y., & Morimoto, R. I. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.033 · Cited by 68
“The accumulation of misfolded and aggregated disease proteins is increasingly recognized as a common pathological mechanism in many neurodegenerative disorders [137].”
BackgroundFurth, N., Gertman, O., Shiber, A., Alfassy, O. S., Cohen, I., Rosenberg, M. M., Kleinberger-Doron, N., Friedler, A., & Ravid, T. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-05-0463 · Cited by 67
“The exposure of buried internal hydrophobic residues is a sign of protein misfolding that may result in irreversible protein inactivation or aggregation (Soto, 2003).”
BackgroundThe Influence of Selection for Protein Stability on dN/dS Estimations
Dasmeh, P., Serohijos, A. W. R., Kepp, K. P., & Shakhnovich, E. I. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu223 · Cited by 65
“Furthermore, misfolding is emerging as an important etiological basis of many diseases (Soto 2003; Chiti and Dobson 2006; Serohijos et al. 2008).”
BackgroundProteostasis disturbance in amyotrophic lateral sclerosis
Medinas, D. B., Valenzuela, V., & Hetz, C. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx274 · Cited by 72
Ge, X., Yang, Y., Sun, Y., Cao, W., & Ding, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00396 · Cited by 61
“To study the kinetics of Aβ42 and IAPP amyloid fibrils formation in vitro, human βAmyloid (1-42) and IAPP were purchased from GeneScript (RP10017) and Sigma-Aldrich Co.”
MethodFilamentous Aggregates Are Fragmented by the Proteasome Holoenzyme
Cliffe, R., Sang, J. C., Kundel, F., Finley, D. J., Klenerman, D., & Ye, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.096 · Cited by 64
“Amyloidogenic proteins have a propensity to misfold and oli-gomerize (Soto, 2003).”
BackgroundJha, N. K., Chen, W., Kumar, S., Dubey, R., Tsai, L.-W., Kar, R., Jha, S. K., Gupta, P. K., Sharma, A., Gundamaraju, R., et al. (2022) · Open Biology · doi:10.1098/rsob.210289 · Cited by 67
“Neurological disorders are characterized by a gradual and progressive loss of neurons, which ultimately affects the steadystate homeostasis of the human nervous system and thereby functions such as abstract thinking, movement, emotions, cognition and memory [1].”
BackgroundKim, D., Hwang, H.-Y., Kim, J. Y., Lee, J. Y., Yoo, J. S., Marko-Varga, G., & Kwon, H. J. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00638 · Cited by 61
Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
Marshall, K. E., Vadukul, D. M., Staras, K., & Serpell, L. C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03464-4 · Cited by 61
Chow, M. K. M., Paulson, H. L., & Bottomley, S. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.064 · Cited by 59
Chen, Y., Li, Q., Li, Q., Xing, S., Liu, Y., Liu, Y., Chen, Y., Liu, W., Feng, F., & Sun, H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02038 · Cited by 59
Kim, S. B., Dsilva, C. J., Kevrekidis, I. G., & Debenedetti, P. G. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4913322 · Cited by 64
DeToma, A. S., Krishnamoorthy, J., Nam, Y., Lee, H. J., Brender, J., Kochi, A., Lee, D., Onnis, V., Congiu, C., Manfredini, S., et al. (2014) · Chemical Science · doi:10.1039/c4sc01531b · Cited by 61
Misfolding of the amyloid β‐protein: A molecular dynamics study
Flöck, D., Colacino, S., Colombo, G., & Nola, A. D. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20683 · Cited by 58
“of these transitions in the pathway going from monomers to fibrils, one leading to soluble, low-molecular-weight oligomers, and the other leading to short, flexible, rodlike protofibrils.(29) Interestingly, there seem to exist common structural features for oligomers, as has been suggested by the finding that a common…”
BackgroundSurviving protein quality control catastrophes – from cells to organisms
Schneider, K., & Bertolotti, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.173047 · Cited by 61
“…diseases share a common pathological hallmark – they are caused by the progressive dysfunction and death of specific nerve cells in selective regions of the brain or the peripheral nervous system, which are the result of the accumulation of specific proteins of aberrant conformations (Soto, 2003).”
West, J. D., Wang, Y., & Morano, K. A. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300264x · Cited by 64
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy
Rodríguez‐Enríquez, F., Costas-Lago, M. C., Besada, P., Alonso-Pena, M., Torres-Terán, I., Viña, D., Fontenla, J. A., Sturlese, M., Moro, S., Quezada, E., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104203 · Cited by 58
“In AD the affected brain regions are hippocampus, cortex and neocortex, leading to dementia, while in PD the dopaminergic neurons of the substantia nigra are destroyed resulting in a significant dopamine deficiency in striatum giving rise to a movement disorder which affects both motor and non-motor functions [2].”
BackgroundChen, J., Bassot, A., Giuliani, F., & Simmen, T. (2021) · Cells · doi:10.3390/cells10071789 · Cited by 63
“An interesting consequence of the classification of neurodegenerative syndromes as general protein misfolding disorders [184] is the activation of ER stress signaling from the formation of protein aggregates in the cytoplasm of CNS cells [6].”
BackgroundÜnal-Çevik, I., Özdemir, Y., Yemişçi, M., Lüle, S., Gürer, G., Can, A., Müller, V., Kahle, P. J., & Dalkara, T. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.170 · Cited by 60
“Under pathologic conditions, α -synuclein aggregates to form neuronal inclusions in several neurodegenerative diseases (”
BackgroundProtein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 72
“Abnormal accumulation of aggregated proteins is a common neuropathological feature of several neurodegenerative disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease (HD) and many other disorders [1].”
BackgroundLipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein
Majewski, J., Jones, E. M., Vander Zanden, C. M., Biernat, J., Mandelkow, E., & Chi, E. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-70208-6 · Cited by 56
TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins
Lyu, L., Chen, Z., & McCarty, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1956105 · Cited by 61
“The accumulation of misfolded proteins and protein aggregates is a central pathological feature of many neurodegenerative diseases, such as Alzheimer, Parkinson, and Huntington [9].”
BackgroundCyclic Amplification of Prion Protein Misfolding
Barria, M. A., Gonzalez-Romero, D., & Soto, C. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_14 · Cited by 64
Self-citationNoh, J.-Y., Lee, H., Song, S., Kim, N. S., Im, W., Kim, M., Seo, H., Chung, C.-W., Chang, J.-W., Ferrante, R. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807620200 · Cited by 57
Shah, S. Z. A., Zhao, D., Hussain, T., & Yang, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.004 · Cited by 55
“, 2008), or whether it is not toxic by itself, but instead activates neurotoxic signaling pathways (Soto, 2003).”
BackgroundmiR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
Xu, J., Zheng, Y., Wang, L., Liu, Y., Wang, X., Li, Y., & Chi, G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01091-6 · Cited by 55
“Although distinct NDDs have different protein aggregates, the protein misfolding process is remarkably similar (Bennett 2005; Ross and Poirier 2004; Soto 2003; Soto and Pritzkow 2018).”
BackgroundArmijo, E., Edwards, G. A., Flores, A., Vera, J. R., Shahnawaz, M., Moda, F., González, C., Sanhueza, M., & Soto, C. A. (2021) · Cells · doi:10.3390/cells10071802 · Cited by 60
“The accumulation of misfolded protein aggregates in the form of extracellular amyloid plaques and intracellular NFTs are the pathognomonic features of AD [2,54].”
BackgroundSelf-citationStumptner, C., Fuchsbichler, A., Zatloukal, K., & Denk, H. (2007) · Hepatology · doi:10.1002/hep.21744 · Cited by 56
Probing the Nucleus Model for Oligomer Formation during Insulin Amyloid Fibrillogenesis
Pease, L. F., Sorci, M., Guha, S., Tsai, D., Zachariah, M. R., Tarlov, M. J., & Belfort, G. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.10.010 · Cited by 61
Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
Kuiper, E. F. E., de Mattos, E. P., Jardim, L. B., Kampinga, H. H., & Bergink, S. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00145 · Cited by 63
“PolyQ aggregates can impede cellular protein homeostasis, loss of which is also observed in many other neurodegenerative diseases (Soto, 2003).”
BackgroundFunctional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.